Skip to main content
Clinical Trials/NCT06758362
NCT06758362
Active, not recruiting
Not Applicable

Comparison of Online EMDR Therapy and CBT for PTSD Symptoms Following the Kahramanmaraş Earthquakes: a Randomized Controlled triaL

Istanbul Nisantasi University1 site in 1 country89 target enrollmentDecember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post Traumatic Stress Disorder PTSD
Sponsor
Istanbul Nisantasi University
Enrollment
89
Locations
1
Primary Endpoint
Reduction in PTSD Symptom Severity Measured by the PTSD Checklist for DSM-5 (PCL-5)
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

This study compares two evidence-based therapies, Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Behavioral Therapy (CBT), in reducing symptoms of post-traumatic stress disorder (PTSD) among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. A total of 89 participants diagnosed with PTSD were randomly assigned to one of three groups: EMDR therapy, CBT therapy, or a no-treatment control group. Each participant in the treatment groups received 12 weekly, one-on-one, 50-minute therapy sessions delivered remotely via a secure online platform. PTSD and related symptoms (depression, anxiety, and emotion dysregulation) were assessed at three time points: before therapy (T1), after the 6th session (T2), and after the 12th session (T3). This study aims to evaluate which therapy yields stronger improvements in PTSD and related psychological outcomes when delivered remotely in a disaster-affected population.

Detailed Description

This randomized controlled trial aimed to compare the effectiveness of two trauma-focused psychotherapeutic interventions-Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Behavioral Therapy (CBT)-in alleviating post-traumatic stress disorder (PTSD) symptoms among adult survivors of the 2023 Kahramanmaraş earthquakes in Türkiye. These earthquakes caused large-scale devastation across 11 cities and resulted in significant psychological distress, including high rates of PTSD. Study Objectives: The primary objective was to determine whether EMDR or CBT is more effective in reducing PTSD symptoms, as measured by the PTSD Checklist for DSM-5 (PCL-5). Secondary objectives included examining changes in depressive symptoms, anxiety, and emotion regulation difficulties over the course of treatment. Study Design: This was an open-label, three-arm, randomized controlled trial. A total of 89 adult participants (aged 18-65) who met DSM-5 criteria for PTSD (based on clinical interview and PCL-5 scores) were randomly assigned to one of three groups: EMDR Therapy Group (n = 30) CBT Therapy Group (n = 30) No-Treatment Control Group (n = 29) Intervention Delivery: Each participant in the therapy arms received 12 weekly, 50-minute, one-on-one sessions delivered remotely via Microsoft Teams. The control group received no intervention during the study period but underwent the same assessments. Intervention Details: EMDR Therapy: Delivered by certified EMDR therapists using the standard 8-phase protocol, adapted for remote delivery with visual and tactile bilateral stimulation. CBT Therapy: Delivered by certified CBT therapists following trauma-focused CBT protocols, including psychoeducation, cognitive restructuring, and behavioral activation. Outcome Measures: Primary Outcome: PTSD symptoms assessed using the PCL-5 at three time points: baseline (T1), after the 6th session (T2), and after the 12th session (T3). Secondary Outcomes: Depression (BDI-II), anxiety (BAI), and emotion regulation (DERS). Supervision and Quality Control: All therapists were supervised weekly by a senior psychiatrist. A fidelity monitoring committee reviewed random session recordings for quality control. Ethical Considerations: The study was approved by the Üsküdar University Non-Invasive Research Ethics Committee (Approval No: 61351342/020-316). Informed consent and publication consent were obtained from all participants. Timeline: Recruitment: January-March 2025 Intervention: April-June 2025 Follow-Up: A separate long-term follow-up is planned and will be reported in a subsequent study. Expected Outcomes: The study aims to provide empirical evidence on the feasibility and effectiveness of online EMDR and CBT for PTSD in disaster-affected populations, informing scalable intervention strategies for future post-disaster mental health services.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
July 15, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Istanbul Nisantasi University
Responsible Party
Principal Investigator
Principal Investigator

Metin Çınaroğlu

Assistant Professor in Psychology Department, Principle investigator

Istanbul Nisantasi University

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18-65 years.
  • Diagnosed with Post-Traumatic Stress Disorder (PTSD) based on the PTSD ---Checklist for DSM-5 (PCL-5) and Clinician-Administered PTSD Scale (CAPS-5).
  • Resided in the Kahramanmaraş earthquake-affected region during the disaster.
  • No current psychiatric medication or ongoing psychotherapy.
  • No history of psychiatric disorders that may interfere with PTSD treatment (e.g., bipolar disorder, schizophrenia, substance-related disorders).
  • Ability to attend weekly, one-on-one, 50-minute online therapy sessions for 24 weeks.
  • Provided written informed consent and psychiatric clearance for study participation.

Exclusion Criteria

  • Individuals currently undergoing psychotherapy or using psychiatric medications.
  • Diagnosis of bipolar disorder, schizophrenia, substance-related disorders, or other psychiatric conditions that may interfere with treatment.
  • Inability to commit to 24 weeks of therapy sessions or attend sessions online.
  • Severe cognitive impairment preventing participation in therapy.
  • Failure to provide written informed consent or psychiatric clearance.

Outcomes

Primary Outcomes

Reduction in PTSD Symptom Severity Measured by the PTSD Checklist for DSM-5 (PCL-5)

Time Frame: Time Frame: Baseline (Before therapy begins) After the 6th session (Mid-therapy, approximately 6 weeks) After the 12th session (Post-therapy, approximately 12 weeks) Six months post-therapy

The primary outcome will measure changes in PTSD symptom severity using the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5), a validated self-report questionnaire designed to assess PTSD symptom severity based on DSM-5 criteria. Scale Details: Minimum Score: 0 Maximum Score: 80 Score Interpretation: Higher scores indicate worse PTSD symptom severity, while lower scores indicate improvement. Assessment Time Points: Baseline (Before therapy begins) After the 6th session (Mid-therapy, approximately 6 weeks) After the 12th session (Post-therapy, approximately 12 weeks) The analysis will focus on changes in total PCL-5 scores across these time points to compare the effectiveness of EMDR and CBT therapies in addressing PTSD symptoms relative to the Control Group.

Secondary Outcomes

  • Change in depressive symptoms as measured by the Beck Depression Inventory-II (BDI-II)(Baseline (pre-treatment), after session 6 (mid-treatment), and after session 12 (post-treatment))
  • Change in anxiety symptoms as measured by the Beck Anxiety Inventory (BAI)(Baseline (pre-treatment), after session 6 (mid-treatment), and after session 12 (post-treatment))
  • Change in emotion regulation difficulties as measured by the Difficulties in Emotion Regulation Scale (DERS)(Baseline (pre-treatment), after session 6 (mid-treatment), and after session 12 (post-treatment))

Study Sites (1)

Loading locations...

Similar Trials